Astera Labs (ALAB) EBT (2023 - 2026)

Astera Labs (ALAB) has reported EBT for 4 consecutive years, with $102.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBT rose 102.97% year-over-year to $102.8 million; the trailing twelve-month figure through Jun 2026 stood at $322.0 million (up 278.42% YoY), and the FY2025 full-year result was $218.2 million, up 366.76% from the prior year.
• EBT rose to $102.8 million in Q2 2026 per ALAB's latest filing, from $73.4 million in the prior quarter.
• Across five years, EBT topped out at $102.8 million in Q2 2026 and bottomed at -$80.4 million in Q1 2024.
• Historically, EBT has averaged $20.7 million across 4 years, with a median of $10.7 million in 2023.
• The sharpest annual moves came in 2024 and 2025: EBT sank 363.98% in 2024, then jumped 3216.57% in 2025.
• Over 4 years, EBT stood at $10.7 million in 2023, then increased by 0.07% to $10.7 million in 2024, then jumped by 637.39% to $78.9 million in 2025, then jumped by 30.3% to $102.8 million in 2026.
• According to Business Quant data, EBT over the past three periods registered $102.8 million, $73.4 million, and $78.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.